324 related articles for article (PubMed ID: 28346852)
1. Preoperative Lymphedema-Related Risk Factors in Early-Stage Breast Cancer.
Iyigun ZE; Duymaz T; Ilgun AS; Alco G; Ordu C; Sarsenov D; Aydin AE; Celebi FE; Izci F; Eralp Y; Ozmen V
Lymphat Res Biol; 2018 Feb; 16(1):28-35. PubMed ID: 28346852
[TBL] [Abstract][Full Text] [Related]
2. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.
Helyer LK; Varnic M; Le LW; Leong W; McCready D
Breast J; 2010; 16(1):48-54. PubMed ID: 19889169
[TBL] [Abstract][Full Text] [Related]
3. Growing Insights into Breast Cancer-Related Lymphedema.
Rockson SG
Lymphat Res Biol; 2018 Feb; 16(1):1. PubMed ID: 29432070
[No Abstract] [Full Text] [Related]
4. Correlation of Bioimpedance Spectroscopy with Risk Factors for the Development of Breast Cancer-Related Lymphedema.
Vicini F; Shah C; Whitworth P; Walker M; Shi J
Lymphat Res Biol; 2018 Dec; 16(6):533-537. PubMed ID: 30133336
[No Abstract] [Full Text] [Related]
5. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study.
Soran A; Ozmen T; McGuire KP; Diego EJ; McAuliffe PF; Bonaventura M; Ahrendt GM; DeGore L; Johnson R
Lymphat Res Biol; 2014 Dec; 12(4):289-94. PubMed ID: 25495384
[TBL] [Abstract][Full Text] [Related]
6. The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer.
Rebegea L; Firescu D; Dumitru M; Anghel R
Chirurgia (Bucur); 2015; 110(1):33-7. PubMed ID: 25800313
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for breast cancer-related lymphedema: correlation with docetaxel administration.
Aoishi Y; Oura S; Nishiguchi H; Hirai Y; Miyasaka M; Kawaji M; Shima A; Nishimura Y
Breast Cancer; 2020 Sep; 27(5):929-937. PubMed ID: 32270417
[TBL] [Abstract][Full Text] [Related]
8. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
9. Utilization of bioelectrical impedance analysis for detection of lymphedema in breast Cancer survivors: a prospective cross sectional study.
Lim SM; Han Y; Kim SI; Park HS
BMC Cancer; 2019 Jul; 19(1):669. PubMed ID: 31286884
[TBL] [Abstract][Full Text] [Related]
10. Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema.
Kaufman DI; Shah C; Vicini FA; Rizzi M
Breast Cancer Res Treat; 2017 Dec; 166(3):809-815. PubMed ID: 28831632
[TBL] [Abstract][Full Text] [Related]
11. Donor-Site Lymphedema Following Lymph Node Transfer for Breast Cancer-Related Lymphedema: A Systematic Review of the Literature.
Demiri E; Dionyssiou D; Tsimponis A; Goula OC; Mιlothridis P; Pavlidis L; Spyropoulou GA; Foroglou P
Lymphat Res Biol; 2018 Feb; 16(1):2-8. PubMed ID: 29087763
[TBL] [Abstract][Full Text] [Related]
12. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
Zou L; Liu FH; Shen PP; Hu Y; Liu XQ; Xu YY; Pen QL; Wang B; Zhu YQ; Tian Y
Breast Cancer; 2018 May; 25(3):309-314. PubMed ID: 29397555
[TBL] [Abstract][Full Text] [Related]
13. Breast Cancer-Related Lymphedema: Differentiating Fat from Fluid Using Magnetic Resonance Imaging Segmentation.
Sen Y; Qian Y; Koelmeyer L; Borotkanics R; Ricketts R; Mackie H; Lam TC; Shon KH; Suami H; Boyages J
Lymphat Res Biol; 2018 Feb; 16(1):20-27. PubMed ID: 28346854
[TBL] [Abstract][Full Text] [Related]
14. The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients.
Ikeda K; Ogawa Y; Kajino C; Deguchi S; Kurihara S; Tashima T; Goto W; Nishiguchi Y; Tokunaga S; Fukushima H; Inoue T
Eur J Surg Oncol; 2014 Jul; 40(7):818-23. PubMed ID: 24768416
[TBL] [Abstract][Full Text] [Related]
15. Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients?
Tausch C; Baege A; Dietrich D; Vergin I; Heuer H; Heusler RH; Rageth C
Eur J Surg Oncol; 2013 Aug; 39(8):880-6. PubMed ID: 23735162
[TBL] [Abstract][Full Text] [Related]
16. Axillary reverse mapping in breast cancer: a Canadian experience.
Kuusk U; Seyednejad N; McKevitt EC; Dingee CK; Wiseman SM
J Surg Oncol; 2014 Dec; 110(7):791-5. PubMed ID: 25053441
[TBL] [Abstract][Full Text] [Related]
17. Risk of secondary lymphedema in breast cancer survivors is related to serum phospholipid fatty acid desaturation.
Ryu E; Yim SY; Do HJ; Lim JY; Yang EJ; Shin MJ; Lee SM
Support Care Cancer; 2016 Sep; 24(9):3767-74. PubMed ID: 27041742
[TBL] [Abstract][Full Text] [Related]
18. Time trend of breast cancer-related lymphedema according to body mass index.
Ogiya A; Kimura K; Ueno T; Iwase T; Ohno S
Eur J Surg Oncol; 2024 Jun; 50(6):108350. PubMed ID: 38653160
[TBL] [Abstract][Full Text] [Related]
19. Lymph node status and breast cancer-related lymphedema.
Purushotham AD; Bennett Britton TM; Klevesath MB; Chou P; Agbaje OF; Duffy SW
Ann Surg; 2007 Jul; 246(1):42-5. PubMed ID: 17592289
[TBL] [Abstract][Full Text] [Related]
20. Initial axillary staging of breast cancer using ultrasound-guided fine needle aspiration: a liquid-based cytology study.
Schiettecatte A; Bourgain C; Breucq C; Buls N; De Wilde V; de Mey J
Cytopathology; 2011 Feb; 22(1):30-5. PubMed ID: 20337693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
